Sustained factor VIII production in hemophiliac mice 1 year after engraftment with induced pluripotent stem cell-derived factor VIII producing endothelial cells

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 5, 2010, Pages 502-504

  Alipio, Zaida ^a   Adcock, Dorothy M ^c   Waner, Milton ^b   Teresa, M J O ^b   Fink, Louis M ^a   Ward, David C ^a   Ma, Yupo ^a  

^a NEVADA CANCER INSTITUTE   (United States)

^b Vascular and Birthmark Institute of New York   (United States)

^c Esoterix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; KRUPPEL LIKE FACTOR 4; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2; VIRUS PROTEIN;

C57BL 6 MOUSE; CONTROLLED STUDY; EMBRYO CELL; ENDOTHELIUM CELL; ENGRAFTMENT; GENE THERAPY; HEMOPHILIA A; LETTER; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; SKIN FIBROBLAST; SOMATIC CELL;

ANIMALS; BLOOD COAGULATION TESTS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FACTOR VIII; HEMOPHILIA A; INDUCED PLURIPOTENT STEM CELLS; MICE; QUALITY CONTROL; RNA, MESSENGER;

EID: 77954631931     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833580e9     Document Type: Letter

References (10)

1. Roth DA, Tawa NE Jr, O'Brien JM, Treco DA, Selden RF. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med 2001; 344:1735-1742.
2. Fakharzadeh SS, Zhang Y, Sarkar R, Kazazian HH Jr. Correction of the coagulation defect in hemophilia A mice through factor VIII expression in skin. Blood 2000; 95:2799-2805.
3. Serneri GG,Gensini GF, Gensini RA. Correction of the haemostatic defect in haemophiliacs without apparent correction of the coagulation defect. Haemostasis 1974; 3:149-157.
4. Kaufman RJ. Advances toward gene therapy for hemophilia at the millennium. Hum Gene Ther 1999; 10:2091-2107.
5. Kung SH, Hagstrom JN, Cass D, Tai SJ, Lin HF, Stafford DW, High KA. Human factor IX corrects the bleeding diathesis of mice with hemophilia B. Blood 1998; 91:784-790.
6. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451:141-146.
7. Lewitzky M, Yamanaka S. Reprogramming somatic cells towards pluripotency by defined factors. Curr Opin Biotechnol 2007; 18:467-473.
8. Okita K, Ichisaka T, Yamanaka S. Generation of germlinecompetent induced pluripotent stem cells. Nature 2007; 448: 313-317.
9. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
10. Xu D, Alipio Z, Fink LM, Adcock DM, Yang J, Ward DC, Ma Y. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci U S A 2009; 106:808-813.